- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06171399
Cannabis Edibles Packaging Descriptors Experiment
May 2, 2025 updated by: Wake Forest University Health Sciences
The Impact of Cannabis Edibles Packaging Descriptors on Consumer Appeal, Harm Perceptions and Willingness to Try
The purpose of this study is to assess differences in perceptions of product appeal, harm, and subsequent willingness to try cannabis edibles products with/without product descriptors of interest.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Behavioral: "All Natural" descriptor
- Behavioral: "Gluten-free" descriptor
- Behavioral: "Vegan" descriptor
- Behavioral: "100% Organic" descriptor
- Behavioral: "Handcrafted" descriptor
- Behavioral: "Made with live resin" descriptor
- Behavioral: "Fast-acting" descriptor
- Behavioral: "Relax" descriptor
- Behavioral: "Energy Boost" descriptor
- Behavioral: No descriptor (control)
Detailed Description
Cannabis edibles are rapidly leading the legal recreational cannabis market.
They present health harms that are not typical of smoked marijuana, including accidental overconsumption of high levels of Delta-9-tetrahydrocannabinol (THC).
Product packaging plays an important role in influencing perceptions of a product's appeal and potential harm.
This experiment will assign participants to view real cannabis edibles packaging edited with one of nine commonly used product descriptors found on real cannabis edibles products, and ask a series of questions to assess perceptions of product appeal and harm.
One group of participants will serve as the control and will see the same cannabis edibles packaging without any product descriptors.
Study Type
Interventional
Enrollment (Actual)
2521
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- US resident
- Aged 18-65, inclusive
- Up to 13% of participants will be those who identify as Black/African American
- Up to 16% of participants will be those who identify as Hispanic
- Approximately 50% of participants will be past year cannabis users
Exclusion Criteria:
- Does not currently reside in the United States
- Younger than 18 or older than 65
- Does not provide information regarding history of cannabis use
- Otherwise eligible but demographic and/or user group quotas have been met
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: "All Natural" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "All Natural."
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "Gluten-free" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Gluten-free"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "Vegan" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Vegan"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "100% Organic" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "100% Organic"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "Handcrafted" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Handcrafted"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "Made with live resin" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Made with live resin"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "Fast-acting" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Fast-acting"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "Relax" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Relax"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: "Energy Boost" descriptor
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Energy Boost"
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
|
Experimental: No descriptor (control)
Four edible product packages (gummies, chocolate, mints, cookies) without any product descriptors
|
Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest.
All participants will see the same four products, and each condition will see the products with the same descriptor.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Product Appeal
Time Frame: After exposure to product packaging up to 1 minute
|
One item to assess the appeal of the product.
Results will be reported as mean for all products within condition.
Question: How appealing is this product to you? Response Options: (0) Not at all appealing to (10) Very appealing
|
After exposure to product packaging up to 1 minute
|
|
Product Harm Perceptions (Absolute)
Time Frame: After exposure to product packaging up to 1 minute
|
One item to assess participants' opinions of safety of the product.
Results will be reported as the number of each type of response.
Question: How safe do you think it would be to eat the edible in this package?
Response options: (1) Completely unsafe, (2) Somewhat unsafe, (3) Somewhat safe, (4) Completely safe
|
After exposure to product packaging up to 1 minute
|
|
Willingness to Try Free Sample
Time Frame: After exposure to product packaging up to 1 minute
|
One item to assess participants' willingness to try a free sample of the product shown.
Results will be reported as the number of each type of response.
Question: How interested would you be in a free sample of this product?
Response Options: (1) Not at all; (2) Slightly; (3) Somewhat; (4) Moderately; (5) Very
|
After exposure to product packaging up to 1 minute
|
|
Package Appeal
Time Frame: 1 min
|
One item to assess appeal of the packaging of the product.
Results with be reported as mean for all products within conditions.
Question: How appealing is this packaging to you? Response Options: (0) Not at all appealing to (10) Very appealing
|
1 min
|
|
Package Harm Perceptions (Absolute)
Time Frame: After exposure to product packaging up to 1 min
|
One item to assess participants' opinions of product safety based on the packaging.
Results will be reported as the number of each type of response.
Question: How much does this packaging make you think this edible is safe to consume?
Response Options: (1) Not at all; (2) A little; (3) Somewhat; (4) A lot
|
After exposure to product packaging up to 1 min
|
|
Willingness to Try Product
Time Frame: After exposure to product packaging up to 1 min
|
One item to assess the participants' willingness to try the product based on the packaging.
Results will be reported as the number of each type of response.
Question: How much does seeing this packaging make you want to try this edible?
Response Options: (1) Not at all; (2) A little; (3) Somewhat; (4) A lot
|
After exposure to product packaging up to 1 min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appeal to Children Responses
Time Frame: After exposure to product packaging up to 1 minute
|
One item to assess the participants' assessment of the product packaging's potential appeal to children.
Results will be reported as mean for all products within condition.
Questions: How appealing do you think this packaging would be to children?
Response Options: (0) Not at all appealing to (10) Very appealing
|
After exposure to product packaging up to 1 minute
|
|
Product Harm Perceptions (Relative)
Time Frame: After exposure to product packaging up to 1 minute
|
One question assessing participants' opinions of safety of the product compared to other, similar, products.
Results will be reported as the number of each type of response.
Question: Compared to other edible products on the market, how safe do you think the edible in this package is?
Response Options: (1) Much less safe; (2) Somewhat less safe; (3) As safe; (4) Somewhat safer; (5) Much safer
|
After exposure to product packaging up to 1 minute
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perception of Quality
Time Frame: After exposure to product packaging up to 1 minute
|
One item to assess the participants' perceptions of the quality of the product.
Results will be reported as the number of each type of response.
Question: To what extent do you agree or disagree that this looks like a good quality product?
Response options: (1) Strongly disagree to (5) Strongly agree
|
After exposure to product packaging up to 1 minute
|
|
Perception of Good Taste
Time Frame: After exposure to product packaging up to 1 min
|
One item to assess the participants' perceptions of the taste of the product.
Results will be reported as the number of each type of response.
Question: To what extent do you agree or disagree that this edible might taste good?
Response options: (1) Strongly disagree to (5) Strongly agree
|
After exposure to product packaging up to 1 min
|
|
Perception of Healthfulness of Product
Time Frame: After exposure to product packaging up to 1 min
|
One item to asses the participants' perceptions of the healthfulness of the product based on the packaging.
Results will be reported as the number of each type of response.
Question: How much does this packaging make you think this edible is healthy?
Response options: (1) Not at all; (2) A little; (3) Somewhat; (4) A lot
|
After exposure to product packaging up to 1 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Beth Reboussin, PhD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2024
Primary Completion (Actual)
April 15, 2024
Study Completion (Actual)
April 15, 2024
Study Registration Dates
First Submitted
December 5, 2023
First Submitted That Met QC Criteria
December 5, 2023
First Posted (Actual)
December 14, 2023
Study Record Updates
Last Update Posted (Actual)
May 9, 2025
Last Update Submitted That Met QC Criteria
May 2, 2025
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00104038
- R01DA053209 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis Use
-
Anders Fink-Jensen, MD, DMSciNeurobiology Research Unit, RigshospitaletRecruitingCannabis Dependence | Cannabis Abuse | Cannabis Use Disorder | Cannabis Use Disorders | Cannabis AddictionDenmark
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingMarijuana Abuse | Marijuana Use | Addiction | Substance Use | Cannabis Dependence | Substance Use Disorders | Cannabis Use | Substance Abuse | Addiction, Substance | Marijuana Dependence | Substance Dependence | Marijuana Smoking | Cannabis Abuse | Cannabis Use Disorder | Marijuana | Cannabis Intoxication | Substance Related... and other conditionsUnited States
-
Stanford UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)Enrolling by invitation
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Centre hospitalier de l'Université de Montréal...CompletedCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
Medical University of South CarolinaNational Cancer Institute (NCI)RecruitingTobacco Use Disorder | Marijuana Use | Tobacco Use Cessation | Cannabis Use | Cannabis Use DisorderUnited States
-
Boston Children's HospitalNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use | Cannabis Use Disorder | Cannabis IntoxicationUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Recruiting
-
Brigham and Women's HospitalNot yet recruitingCannabis Use Disorder
Clinical Trials on "All Natural" descriptor
-
Sprim Advanced Life SciencesArtsana S.p.a.CompletedFeeding Behavior
-
Wenxiang WangShanghai Houchao Biotechnology Co., LtdUnknownNon-small Cell Lung CancerChina
-
Hampton VA Medical CenterCompletedPersonality Disorders | Depression | Bipolar Disorder | Substance Use Disorders | PsychosisUnited States
-
Acibadem UniversityUnknownInfertility, FemaleTurkey
-
Alpha - Bio Tec Ltd.Unknown
-
Alcon ResearchCompleted
-
NovoBliss Research Pvt LtdTTK Healthcare Ltd - Protective Devices DivisionCompletedHealthy FemalesIndia
-
Pennington Biomedical Research CenterOhio State UniversityCompleted
-
Envita Medical Center, Inc.SuspendedGlioma | Breast Cancer | Pancreatic Cancer | Prostate Cancer | Colon Cancer | Hepatocellular Cancer | Squamous Cell Lung CancerUnited States
-
Taipei Medical UniversityCompleted